Antitrust Law: Pharmaceutical Industry

During the past several years, there has been an increase in antitrust enforcement directed at the pharmaceutical industry, both in the United States and in Europe, primarily focused on conduct by branded pharmaceutical companies that might affect the timing and effectiveness of entry by less costly generic drugs. The use of novel antitrust theories and tactics as a method of policing this market is a notable recent development.


Download PDF Back To Listing
Loading data